Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.02
-0.14 (-1.67%)
Jun 5, 2025, 4:00 PM - Market closed
Addex Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Addex Therapeutics stock has a target of 30, which predicts a 274.06% increase from the current stock price of 8.02.
Price Target: $30.00 (+274.06%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 2, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Addex Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +274.06% | Oct 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +274.06% | Aug 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +274.06% | Jul 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 23, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $420 → $300 | Strong Buy | Maintains | $420 → $300 | +3,640.65% | May 31, 2022 |
Financial Forecast
Revenue This Year
765.00K
from 410.04K
Increased by 86.57%
Revenue Next Year
765.00K
from 765.00K
EPS This Year
-0.06
from 0.07
EPS Next Year
-0.04
from -0.06
Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6M | 1.6M | n/a | ||
| Avg | 765,000 | 765,000 | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 284.1% | 105.9% | - | ||
| Avg | 86.6% | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.05 | -0.04 |
| Avg | -0.06 | -0.04 |
| Low | -0.07 | -0.04 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.